iTeos Therapeutics 주식 가격. ITOS - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

가격

9.95

매수가

9.60

매도가

12.00

거래량

800,554

9.07 일간 변동폭 10.21

8.20 52주 범위 18.75

market_cap

363.392M

전일 종가

9.07

개장가

9.07

최근 거래 시간

10.1

마지막 거래 시간

재정 규모

US$ 7,823,071

VWAP

9.7721

평균 볼륨(3m)

545,510

발행 주식

36,521,845

배당수익률

주가수익률

-3.23

주당순이익(EPS)

-3.08

매출

12.6M

순이익

-112.64M

ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoin... ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody. 더 보기

섹터

Biological Pds,ex Diagnstics

산업

Biological Pds,ex Diagnstics

웹사이트

www.iteostherapeutics.com

본부

Wilmington, Delaware, USA

설립됨

iTeos Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker ITOS. The last closing price for iTeos Therapeutics was US$9.07. Over the last year, iTeos Therapeutics shares have traded in a share price range of US$ 8.20 to US$ 18.75.

iTeos Therapeutics currently has 36,521,845 shares in issue. The market capitalisation of iTeos Therapeutics is US$331.25 million. iTeos Therapeutics has a price to earnings ratio (PE ratio) of -3.23.

Form 8-K - Current report

iTeos Announces Clinically Meaningful Objective Response Rate Observed at Every Dose in Follow-up Interim Analysis of GALAXIES Lung-201 Study of Belrestotug + Dostarlimab in First-Line, PD-L1 High Non-Small Cell Lung Cancer Patients

- Clinically meaningful objective response rate (ORR) of 63.3-76.7% observed with belrestotug + dostarlimab combinations, with confirmed ORR (cORR) at ~60% for every dose- >30% cORR difference...

iTeos to Participate in Upcoming Investor Conferences

WATERTOWN, Mass. and GOSSELIES, Belgium, Aug. 28, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) (“iTeos”), a clinical-stage biopharmaceutical company pioneering the discovery...

iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 GALAXIES Lung-201 Interim Data at the European Society for Medical Oncology Congress 2024

WATERTOWN, Mass. and GOSSELIES, Belgium, Aug. 20, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) (“iTeos”), a clinical-stage biopharmaceutical company pioneering the discovery...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0.34	3.53798126951	9.61	10.22	8.74	460218	9.46221856	CS
4	-7.03	-41.4016489988	16.98	17.52	8.74	918744	11.28316119	CS
12	-6.39	-39.1064871481	16.34	18.13	8.74	545510	13.37594027	CS
26	-2.29	-18.7091503268	12.24	18.75	8.74	481163	14.4235375	CS
52	0.15	1.5306122449	9.8	18.75	8.2	430292	12.6512133	CS
156	-16.99	-63.0660727543	26.94	52.43	8.2	388535	19.67689365	CS
260	-9.75	-49.4923857868	19.7	52.43	8.2	351607	21.38437739	CS

가장 활성
% 상승자
% 패자

기호	가격	볼륨
CAMPCAMP4 Therapeutics Corporation	10.75 (2,587.50%)	378.47k
TWGTop Wealth Group Holding Ltd	US$ 7.14 (233.64%)	154.23M
NIVFNewGenIvf Group Ltd	US$ 0.98 (63.42%)	58.51M
ATIFATIF Holdings Ltd	US$ 1.235 (58.33%)	3.85M
VERBVerb Technology Company Inc	US$ 7.91 (51.82%)	15.55M
BYUBAIYU Holdings Inc	US$ 0.299 (-35.28%)	11.11M
TURBTurbo Energy SA	US$ 2.1511 (-29.01%)	3.2M
SMSTDefiance Daily Target 1.5X Short MSTR ETF	US$ 7.898 (-23.62%)	993.33k
VEEAVeea Inc	US$ 3.27 (-23.24%)	284.95k
INHDInno Holdings Inc	US$ 3.74 (-22.41%)	257.75k
JTAIJet AI Inc	US$ 0.1009 (23.50%)	340.09M
CDTConduit Pharmaceuticals Inc	US$ 0.116 (13.28%)	270.97M
NVDANVIDIA Corporation	US$ 134.80 (-0.01%)	170.27M
LUXHLuxUrban Hotels Inc	US$ 0.0532 (5.35%)	165.94M
TWGTop Wealth Group Holding Ltd	US$ 7.14 (233.64%)	154.23M